EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pathologic response after total neoadjuvant therapy in stage II–III rectal cancer: preliminary results from a prospective study from Vietnam

Vo Duc Hieu, Phan Thi Hong Duc, Nguyen Hoang Quy, Vo Ngoc Huan, Le Quoc Khanh, Le Hoang Dinh Nguyen, Pham Thi Minh Thu, Pham Hung Cuong

Frontiers in Oncology · 24.03.2026 · 16

DOI: 10.3389/fonc.2026.1774856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 24.03.2026. Verfasst von Vo Duc Hieu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Total neoadjuvant therapy (TNT) is increasingly recommended for locally advanced rectal cancer (LARC), yet data from developing countries remain limited. In Vietnam, constraints in diagnostic access, radiotherapy availability, and multidisciplinary coordination may affect treatment feasibility and outcomes.

Objective

To evaluate pathological response, safety, and perioperative outcomes of TNT for stage II–III rectal cancer in a Vietnamese oncology center.

Methods

This prospective single-arm study enrolled 101 patients who received long-course chemoradiotherapy followed by consolidation capecitabine–oxaliplatin (CAPOX) or 5-fluorouracil/leucovorin–oxaliplatin (FOLFOX)before total mesorectal excision. Pathologic response and tumor regression grade were assessed.

Results

Among 95 resected patients, pathological complete response (pCR) was 35.7%, and good regression (TRG 0–1) was achieved in 70.4%. Treatment completion was high (94.1%), with acceptable toxicity and no treatment-related mortality.

Conclusion

TNT is feasible, safe, and achieves response outcomes comparable to global benchmarks, supporting its integration into rectal cancer management in resource-limited settings.

Schlagwörter

Stichwörter der Autor:innen

CapeOXFOLFOXchemoradiotherapypathological complete responserectal cancertotal neoadjuvant therapytumor regression

Autor:innen und Institutionen

  • Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam.
  • Department of Oncology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
  • Department of Oncology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.

Zitieren

APA

Duc Hieu, V., Duc, P. T. H., Quy, N. H., Huan, V. N., Khanh, L. Q., Nguyen, L. H. D., Thu, P. T. M., & Cuong, P. H. (2026). Pathologic response after total neoadjuvant therapy in stage II–III rectal cancer: preliminary results from a prospective study from Vietnam. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1774856

Vancouver

Duc Hieu V, Duc PTH, Quy NH, Huan VN, Khanh LQ, Nguyen LHD, et al. Pathologic response after total neoadjuvant therapy in stage II–III rectal cancer: preliminary results from a prospective study from Vietnam. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1774856

BibTeX
@article{DucHieu2026,
  author = {Duc Hieu, Vo and Duc, Phan Thi Hong and Quy, Nguyen Hoang and Huan, Vo Ngoc and Khanh, Le Quoc and Nguyen, Le Hoang Dinh and Thu, Pham Thi Minh and Cuong, Pham Hung},
  title = {Pathologic response after total neoadjuvant therapy in stage II–III rectal cancer: preliminary results from a prospective study from Vietnam},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1774856}
}
Kostenlos starten →